XML 49 R33.htm IDEA: XBRL DOCUMENT v3.25.4
Stockholders’ Equity and Equity Incentive Plans (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule of Disclosure of Share-based Compensation Arrangements by Share-based Payment Award
The following table summarizes stock option activity and related information under the Company’s equity incentive plans (shares and aggregate intrinsic value in thousands):
Options Outstanding
Number of Shares Underlying Outstanding OptionsWeighted-Average Exercise PriceWeighted Average Remaining Contractual Term (Years)
Aggregate Intrinsic Value
Outstanding — December 31, 20247,893 $10.68 5.71$50,372 
Options granted986 15.65 
Options exercised(953)1.84 
Options canceled(97)16.39 
Options expired(41)21.79 
Outstanding — December 31, 20257,788 $12.26 5.67$19,475 
Vested and exercisable — December 31, 20255,949 $11.25 4.86$19,475 
The following table summarizes RSU activity and related information under the Company’s 2020 Plan:
RSUs
Number of Shares (in thousands)
Weighted-Average Grant Date Fair Value per ShareAggregate Intrinsic Value (in thousands)
Unvested — December 31, 20243,687 $17.68 $54,167 
Granted2,047 14.39 
Vested(1,681)17.96 
Canceled/Forfeited(376)16.49 
Unvested — December 31, 20253,677 $15.85 $32,618 
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The fair value of stock options granted under the Company’s equity incentive plans was estimated using the following assumptions:
Year Ended December 31,
202520242023
Fair market value of common stock
$15.65-$15.65
$15.38-$16.34
$12.56-$16.94
Expected term (in years)
5.0-7.0
5.0-7.0
5.0-7.0
Risk-free interest rate
4.4%-4.4%
4.0%-4.2%
3.5%-4.0%
Expected volatility
54%-57%
55%-58%
55%-59%
Dividend rate—%—%—%
Weighted-average grant date fair value of options granted$8.83$8.78$8.58
The fair value of purchase right granted the under the Company’s 2020 Employee Stock Purchase Plan was estimated using the following assumptions:
Year Ended December 31,
202520242023
Expected term (in years)
0.5-1.0
0.5-1.0
0.5-1.0
Risk-free interest rate
3.6%-3.7%
4.3%-5.4%
5.4%-5.1%
Expected volatility
74%-81%
53%-65%
48%-59%
Dividend rate—%—%—%
Schedule of Share-based Payment Arrangement, Expensed and Capitalized, Amount
Total stock-based compensation expense recognized in the consolidated statements of operations was as follows (in thousands):
Year Ended December 31,
202520242023
Cost of revenue$1,854 $1,855 $1,472 
Technology and development6,088 6,313 4,346 
Sales and marketing13,703 13,407 10,462 
General and administrative16,733 16,101 12,582 
Total stock-based compensation expense38,378 37,676 28,862 
Tax benefit from stock-based compensation(8,117)(7,728)(5,695)
Total stock-based compensation expense, net of tax effect$30,261 $29,948 $23,167